NeuroOne expects FY2026 product revenue of about $10.5 million, top of guidance range

Bitget2026/10/05 13:21

NeuroOne expects fiscal Q4 product revenue of about $3.8 million, up 38.4% from about $2.7 million a year earlier. Full-year product revenue forecast at about $10.5 million, up 15.6%, matching the top end of its $9.2 million-$10.5 million range. Record $4.5 million purchase order secured in September; about $1 million shipped, with $3.6 million slated for fiscal Q1-Q2 2027. Open purchase orders for shipments through fiscal Q1 2027 rose to $5.4 million as of Sept. 30, 2026. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Neuroone Medical Technologies Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-106677), on October 05, 2026, and is solely responsible for the information contained therein.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

NeuroOne expects fiscal Q4 product revenue of about $3.8 million, up 38.4% from about $2.7 million a year earlier.
Full-year product revenue forecast at about $10.5 million, up 15.6%, matching the top end of its $9.2 million-$10.5 million range.
Record $4.5 million purchase order secured in September; about $1 million shipped, with $3.6 million slated for fiscal Q1-Q2 2027.
Open purchase orders for shipments through fiscal Q1 2027 rose to $5.4 million as of Sept. 30, 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Neuroone Medical Technologies Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-106677), on October 05, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

NeuroOne expects FY2026 product revenue of about $10.5 million, top of guidance range

You may also like

Crypto prices